BRICS New Delhi Declaration backs Traditional Medicine cooperation, expert group proposed
Synopsis
Key Takeaways
The New Delhi Declaration, adopted at the 18th BRICS Summit, has given a significant push to international cooperation in Traditional, Complementary and Integrative Medicine (TCIM), with member countries welcoming the proposed establishment of a BRICS Expert Working Group on the subject, according to an official statement released on Sunday, 13 September 2026. The move positions India — currently holding the BRICS Chairship — as a central force in shaping a multilateral framework for traditional medicine.
What the Declaration Proposes
The proposed expert working group, to function under the BRICS Health Track, is envisaged as a structured platform for dialogue, collaboration and knowledge exchange among member states on traditional medicine systems. According to the Ministry of AYUSH, the Declaration also calls for greater cooperation in research on medicinal plants and herbal preparations used for therapeutic and preventive purposes.
Notably, the Declaration recognises the shared traditional pharmacopoeias of BRICS countries as a potential foundation for developing safe, effective and affordable therapeutic products — a recognition that could lay the groundwork for jointly developed herbal standards and quality benchmarks across member nations.
What the Government Said
Union Minister Prataprao Jadhav described the inclusion of TCIM in the Declaration as an important step towards strengthening global cooperation in traditional medicine. He said the proposed expert working group would give member states a platform to share knowledge, strengthen research and advance evidence-based approaches.
'India remains committed to taking forward Ayurveda and other traditional systems of medicine through scientific research, quality assurance and international collaboration,' Jadhav said.
Secretary, Ministry of AYUSH, Vaidya Rajesh Kotecha said the Declaration marked a meaningful step towards advancing structured cooperation on TCIM among BRICS countries. He added that the working group could provide a focused forum for sharing evidence, strengthening research collaboration and improving quality and regulatory approaches across member states.
Regulatory and Scientific Dimensions
The Declaration also reaffirmed the importance of ensuring the quality, safety and efficacy of TCIM practices and products through evidence-informed approaches and appropriate regulatory frameworks, in line with national contexts of member states. This signals a move toward harmonised standards rather than uniform mandates — a pragmatic design given the diversity of traditional medicine systems across Brazil, Russia, India, China, South Africa and newer BRICS members.
The Ministry noted that progress on medicinal plants and herbal preparations could open avenues for deeper scientific and technical collaboration, including in documentation, pharmacopoeial standards, quality assurance and development of therapeutic products.
Background and Lead-Up
The development follows the BRICS Meeting on Traditional, Complementary and Integrative Medicine held in Chandigarh on 21 July under India's BRICS Chairship — an event that is widely seen as having laid the groundwork for the Declaration's TCIM provisions. This is part of a broader Indian diplomatic effort to embed Ayurveda and related systems into international health governance frameworks, including earlier moves at the World Health Organization (WHO) and the G20.
As the working group's terms of reference and membership are finalised in the coming months, the pace and depth of actual research collaboration will be closely watched by both health ministries and the traditional medicine industry across BRICS nations.